AIxCrypto Holdings, Inc. earnings releases FFR

AIxCrypto Holdings, Inc. last reported quarterly results on Aug 7, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): diluted EPS of -$0.21. It usually reports 38–47 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 16, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 38–47 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 7, 2026
38 days after quarter end
Q2 FY2026
ended Jun 30, 2026
—
-4
-148.5%
-0.21
+79.0%
May 12, 2026
42 days after quarter end
Q1 FY2026
ended Mar 31, 2026
—
-6
-0.79
+56.6%
Aug 15, 2023
46 days after quarter end
—
ended Jun 30, 2023
—
—
—
Aug 16, 2022
47 days after quarter end
—
ended Jun 30, 2022
—
—
—
May 13, 2022
43 days after quarter end
—
ended Mar 31, 2022
—
—
—
May 1, 2020
31 days after quarter end
—
ended Mar 31, 2020
—
—
—
Nov 14, 2019
45 days after quarter end
—
ended Sep 30, 2019
—
—
—
Aug 14, 2019
45 days after quarter end
—
ended Jun 30, 2019
—
—
—

Company profile

Industry
Finance Services (SIC 6199)
Listed as
FFR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
El Segundo, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1460702
Former names
AIxCrypto Holdings, Inc. (until Sep 29, 2026); Qualigen Therapeutics, Inc. (until Nov 19, 2025); RITTER PHARMACEUTICALS INC (until May 20, 2020)

Other Finance Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.